Poor immunological recovery among severely immunosuppressed antiretroviral therapy-naïve Ugandans.

13 Data from the ART Cohort Collaboration study in Uganda demonstrated that patients with baseline CD4 < 200 cells/μL experienced more toxicities from stavudine, lamivudine, and nevirapine/efavirenz, although these findings did not reach statistical significance. 22 Other baseline prognostic factors that have been associated with poor ART outcomes among HAART patients include advanced age, viral load ≥100,000 copies/mL, AIDS diagnosis, duration of HIV infection, and injection drug use. 6 , 7 , 23 Reports relating ART outcome with sex are contradictory, with some studies reporting a better outcome in females, while others have demonstrated males have done better on ART.

also in 111,027 other papers